Bhatia S (2017) Nanotechnology in drug delivery: fundamentals, design, and applications. CRC

Press

Bhavsar MD, Tiwari SB, Amiji MM (2006) Formulation optimization for the nanoparticles-in-

microsphere hybrid oral delivery system using factorial design. J Control Release 110(2):

422–430

Boles MA, Ling D, Hyeon T, Talapin DV (2016) The surface science of nanocrystals. Nat Mater 15:

141

Centre for Drug Evaluation Taiwan (2017) Regulatory considerations for nanotechnology-related

drug products in Taiwan. https://www.pmda.go.jp/files/000151972.pdf. Accessed 10 Apr 2019

Chauhan MK, Bhatt N (2019) Bioavailability enhancement of polymyxin B with novel drug

delivery: development and optimization using quality-by-design approach. J Pharm Sci 108:

1521–1528

Chavan RB, Modi SR, Bansal AK (2015) Role of solid carriers in pharmaceutical performance of

solid supersaturable SEDDS of celecoxib. Int J Pharm 495(1):374–384

Chaves LL, Costa LSA, Vieira AC, Barreiros L, Segundo MA, Ferreira D et al (2017) pH-sensitive

nanoparticles for improved oral delivery of dapsone: risk assessment, design, optimization and

characterization. Nanomedicine 12(16):1975–1990

Cheng R, Meng F, Deng C, Zhong Z (2015) Bioresponsive polymeric nanotherapeutics for targeted

cancer chemotherapy. Nano Today 10(5):656–670

Chopra D, Gupta KC, Sharma S, Katri M, Singh B, Singh B (2015) Nanostructured drug delivery:

toxicological challenges and safety issues. In: Singh B, Kanwar JR, Katare OP (eds)

Nanomedicine, vol vol 1. Studium Press LLC, USA, pp 493–535

Chung NO, Lee MK, Lee J (2012) Mechanism of freeze-drying drug nanosuspensions. Int J Pharm

437(1–2):42–50

Cochran WC, Cox GM (1992) Experimental design. Wiley, New York

Crommelin DJA, Storm G, Jiskoot W, Stenekes R, Mastrobattista E, Hennink WE (2003)

Nanotechnological approaches for the delivery of macromolecules. J Control Release 87:81–88

Cun D, Jensen DK, Maltesen MJ, Bunker M, Whiteside P, Scurr D et al (2011) High loading

efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by

design optimization and characterization. Eur J Pharm Biopharm 77(1):26–35

Dadkhah D, Navarchian AH, Aref L, Tavakoli N (2014) Application of Taguchi method to

investigate the drug release behavior of poly(acrylamide-co-maleic acid)/montmorillonite

nanocomposite hydrogels. Adv Polym Technol 33(4):1–9

Danhier F, Préat V, Langer R, Anderson DG (2017) Nanoparticle-based drug delivery systems: a

commercial and regulatory outlook as the field matures. Expert Opin Drug Deliv 14(7):851–864

Das B, Sen SO, Maji R, Nayak AK, Sen KK (2017) Transferosomal gel for transdermal delivery of

risperidone: formulation optimization and ex vivo permeation. J Drug Deliv Sci Tec 38:59–71

De Crozals G, Bonnet R, Farre C, Chaix C (2016) Nanoparticles with multiple properties for

biomedical applications: a strategic guide. Nano Today 11(4):435–463

Department of Biotechnology Indian Society of Nanomedicine (2019) Guidelines for evaluation of

nanopharmaceuticals in India. http://www.dbtindia.nic.in/wp-content/uploads/Modified-

Guidelines-for-Evaluation-of-Nanopharmaceuticals-in-India-converted-2.pdf.

Accessed

23

Mar 2019

Dhoble S, Patravale V (2019) Development of anti-angiogenic erlotinib liposomal formulation for

pulmonary hypertension: a QbD approach. Drug Deliv Transl Res 9(5):980–996

Djuris J, Djuric Z (2017) Modeling in the quality by design environment: regulatory requirements

and recommendations for design space and control strategy appointment. Int J Pharm 533(2):

346–356

Durakovic B (2017) Design of experiments application, concepts, examples: state of the art. PEN

5(3):421–439

El-Say KM, Hosny KM (2018) Optimization of carvedilol solid lipid nanoparticles: an approach to

control the release and enhance the oral bioavailability on rabbits. PLoS One 13(8):1–15

344

B. Singh et al.